Abbas-Hanif, A., Modi, N., Smith, S. K., & Majeed, A. (2021). Covid-19 treatments and vaccines must be evaluated in pregnancy. BMJ, n2377. https://doi.org/10.1136/bmj.n2377

The COVID-19 vaccine race | Gavi, the Vaccine Alliance. (n.d.). Retrieved October 8, 2021, from https://www.gavi.org/vaccineswork/covid-19-vaccine-race

Flu and Covid jabs safe to be given at same time, study finds | Vaccines and immunisation | The Guardian. (n.d.). Retrieved October 1, 2021, from https://www.theguardian.com/society/2021/sep/30/flu-covid-jabs-safe-same-time-study?CMP=Share_iOSApp_Other

Mel 💉🩹❤️Get Vaccinated! On Twitter: “#GetVaccinatedNow https://t.co/ewb1vQCvWw” / Twitter. (n.d.). Retrieved August 27, 2021, from https://twitter.com/ScientistMel/status/1430927342361137156

Kadambari, S., & Vanderslott, S. (2021). Lessons about COVID-19 vaccine hesitancy among minority ethnic people in the UK. The Lancet Infectious Diseases, S1473309921004047. https://doi.org/10.1016/S1473-3099(21)00404-7

Waddell, Lily. “Double-Jabbed May Miss Holidays If NHS Errors Mean Records Don’t Save,” July 21, 2021. https://www.standard.co.uk/news/uk/uk-travel-news-vaccine-passport-holidays-covid-b946848.html.

PINHO, A. C. (2021, March 10). EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19 [Text]. European Medicines Agency. https://www.ema.europa.eu/en/news/ema-starts-rolling-review-eli-lilly-antibodies-bamlanivimab-etesevimab-covid-19

How long do COVID vaccines take to start working? (n.d.). Retrieved June 29, 2021, from https://theconversation.com/how-long-do-covid-vaccines-take-to-start-working-161876?utm_source=twitter&utm_medium=bylinetwitterbutton

Lipsitch, M., & Kahn, R. (2021). Interpreting vaccine efficacy trial results for infection and transmission. Vaccine, 39(30), 4082–4088. https://doi.org/10.1016/j.vaccine.2021.06.011

40 Iowa infectious disease doctors recommend COVID-19 vaccines. (n.d.). Retrieved June 28, 2021, from https://eu.desmoinesregister.com/story/opinion/columnists/iowa-view/2021/06/27/iowa-infectious-disease-doctors-recommend-covid-19-vaccines/7777363002/

Duarte-Salles, T., & Prieto-Alhambra, D. (2021). Heterologous vaccine regimens against COVID-19. The Lancet, S0140673621014422. https://doi.org/10.1016/S0140-6736(21)01442-2

Borobia, A. M., Carcas, A. J., Pérez-Olmeda, M., Castaño, L., Bertran, M. J., García-Pérez, J., Campins, M., Portolés, A., González-Pérez, M., García Morales, M. T., Arana-Arri, E., Aldea, M., Díez-Fuertes, F., Fuentes, I., Ascaso, A., Lora, D., Imaz-Ayo, N., Barón-Mira, L. E., Agustí, A., … Torvisco, J. M. (2021). Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): A multicentre, open-label, randomised, controlled, phase 2 trial. The Lancet, S0140673621014203. https://doi.org/10.1016/S0140-6736(21)01420-3

Covid-19 vaccine did not kill every animal it was tested on—Full Fact. (n.d.). Retrieved June 27, 2021, from https://fullfact.org/online/covid-vaccine-animal-testing/

Thompson, M. G., Burgess, J. L., Naleway, A. L., Tyner, H. L., Yoon, S. K., Meece, J., Olsho, L. E. W., Caban-Martinez, A. J., Fowlkes, A., Lutrick, K., Kuntz, J. L., Dunnigan, K., Odean, M. J., Hegmann, K. T., Stefanski, E., Edwards, L. J., Schaefer-Solle, N., Grant, L., Ellingson, K., … Gaglani, M. (2021). Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers—Eight U.S. Locations, December 2020–March 2021. MMWR. Morbidity and Mortality Weekly Report, 70(13), 495–500. https://doi.org/10.15585/mmwr.mm7013e3

Covid vaccine: US trial of AstraZeneca jab confirms safety—BBC News. (n.d.). Retrieved June 26, 2021, from https://www.bbc.co.uk/news/health-56479462

Parry, H. M., Tut, G., Faustini, S., Stephens, C., Saunders, P., Bentley, C., Hilyard, K., Brown, K., Amirthalingam, G., Charlton, S., Leung, S., Chiplin, E., Coombes, N. S., Bewley, K. R., Penn, E. J., Rowe, C., Otter, A., Watts, R., D’Arcangelo, S., … Moss, P. (2021). BNT162b2 Vaccination in People Over 80 Years of Age Induces Strong Humoral Immune Responses with Cross Neutralisation of P.1 Brazilian Variant. SSRN Electronic Journal. https://doi.org/10.2139/ssrn.3816840

Callaway, E. (2021). Mix-and-match COVID vaccines trigger potent immune response. Nature, 593(7860), 491–491. https://doi.org/10.1038/d41586-021-01359-3

Wallis, C. (n.d.). COVID Has Pushed Medical Research into Remote Trials, Benefiting Patients and Scientists. Scientific American. https://doi.org/10.1038/scientificamerican0521-24

Variants, 3 New Covid Vaccines, and Contested Efficacy Claims: A Month of Seismic Shifts and Confusion. (2021, January 31). Absolutely Maybe. https://absolutelymaybe.plos.org/2021/01/31/variants-3-new-covid-vaccines-and-contested-efficacy-claims-a-month-of-seismic-shifts-and-confusion/

Hilda Bastian, PhD. (2021, February 6). Unofficial unnamed AstraZeneca insider says they are doing the interim analysis for the US trial of the Oxford vaccine. AstraZeneca spokesperson says 4-6 weeks till data release. Https://t.co/VUHgbHN02d One is wrong? Or they’ll release only when have FDA minimum follow-up? Https://t.co/LgjfX8AIti [Tweet]. @hildabast. https://twitter.com/hildabast/status/1357862227106095105

ChAdOx1 nCov-19 provides minimal protection against mild-moderate COVID-19 infection from B.1.351 coronavirus variant in young South African adults | University of Oxford. (n.d.). Retrieved February 18, 2021, from https://www.ox.ac.uk/news/2021-02-07-chadox1-ncov-19-provides-minimal-protection-against-mild-moderate-covid-19-infection

Staff, R. (2021, February 6). AstraZeneca thinks shot can stop severe disease from South Africa COVID variant. Reuters. https://www.reuters.com/article/uk-health-coronavirus-astrazeneca-respon-idUKKBN2A60S2

Staff, R. (2021, February 5). AstraZeneca expects U.S. trial results in next 4-6 weeks, research chief says. Reuters. https://www.reuters.com/article/uk-health-coronavirus-astrazeneca-usa-idUSKBN2A522V

Steinhauser, G. (2021, February 7). Rollout of AstraZeneca Covid-19 Vaccine Halted in South Africa After Study. Wall Street Journal. https://www.wsj.com/articles/astrazeneca-vaccine-doesnt-protect-against-mild-and-moderate-cases-from-south-africa-strain-11612700385

Kai Kupferschmidt. (2021, March 16). “I’m not here to give you the outcome of any scientific review”, says EMA director Emer Cooke at start of press conference on AstraZeneca vaccine safety. ‘I’m here to explain the steps in the process, what we’re doing, and when you can expect us to come to a conclusion.’ [Tweet]. @kakape. https://twitter.com/kakape/status/1371811123197001729

the Guardian. ‘Small Number of Facebook Users Responsible for Most Covid Vaccine Skepticism – Report’, 16 March 2021. http://www.theguardian.com/technology/2021/mar/15/facebook-study-covid-vaccine-skepticism.

A Few People Developed a Rare Blood Disorder, Immune Thrombocytopenia, After Getting a COVID Vaccine | Health.com. (n.d.). Retrieved March 17, 2021, from https://www.health.com/condition/infectious-diseases/coronavirus/rare-blood-disorder-covid-vaccine-thrombocytopenia

London, Alex John, and Jonathan Kimmelman. ‘Against Pandemic Research Exceptionalism’. Science 368, no. 6490 (1 May 2020): 476–77. https://doi.org/10.1126/science.abc1731.

November 19: “Randomisation and control in the age of coronavirus?” (Stephen Senn). (2020, October 30). PhilStatWars. https://phil-stat-wars.com/2020/10/30/november-19-randomisation-and-control-in-the-age-of-coronavirus-stephen-senn/

ReconfigBehSci. (2020, October 31). RT @learnfromerror: PHIL STAT FORUM NOVEMBER 19; STEPHEN SENN ‘Randomisation and Control in the Age of Coronavirus?’ https://t.co/hqT8GWTqC… [Tweet]. @SciBeh. https://twitter.com/SciBeh/status/1323311706609721344

Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., Bibi, S., Briner, C., Cicconi, P., Collins, A. M., Colin-Jones, R., Cutland, C. L., Darton, T. C., Dheda, K., Duncan, C. J. A., … Zuidewind, P. (2020). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet, 0(0). https://doi.org/10.1016/S0140-6736(20)32661-1

Siemieniuk, R. A., Bartoszko, J. J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Rochwerg, B., Lamontagne, F., Han, M. A., Liu, Q., Agarwal, A., Agoritsas, T., Chu, D. K., Couban, R., Darzi, A., Devji, T., Fang, B., Fang, C., … Brignardello-Petersen, R. (2020). Drug treatments for covid-19: Living systematic review and network meta-analysis. BMJ, 370. https://doi.org/10.1136/bmj.m2980

Califf, Robert M., Adrian F. Hernandez, and Martin Landray. ‘Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments: Observational Cacophony, Randomized Harmony’. JAMA 324, no. 7 (18 August 2020): 625–26. https://doi.org/10.1001/jama.2020.13319.

Field, S. M., Hoek, J. M., de Vries, Y. A., Linde, M., Pittelkow, M., Muradchanian, J., & van Ravenzwaaij, D. (2020, July 30). Rethinking Remdesivir for COVID-19: A Bayesian Reanalysis of Trial Findings. https://doi.org/10.31222/osf.io/2kam7

Gauri, V. (2020 April 30). Behavioral Public Policy Faces a Crisis. Behavioral Scientist. https://behavioralscientist.org/behavioral-public-policy-faces-a-crisis/

DellaVigna, S & Linos E. (2020). RCTs to scale: Comprehensive evidence from two nudge units. UC Berkeley. https://eml.berkeley.edu/~sdellavi/wp/NudgeToScale2020-03-20.pdf

Matthews, D. (2020, May 20). How exposing healthy volunteers to Covid-19 for vaccine testing would work. Vox. https://www.vox.com/future-perfect/2020/5/20/21258725/covid-19-human-challenge-trials-vaccine-update-sars-cov-2

Callaway, E. (2020). The race for coronavirus vaccines: A graphical guide. Nature, 580(7805), 576–577. https://doi.org/10.1038/d41586-020-01221-y

215 clinical trials

337 clinical trials

Interesting how these two sources contradict each other with regards to why Fleming did not release Penicillin for ten years.

Article: Understanding animal research

Interesting how these two sources contradict each other with regards to why Fleming did not release Penicillin for ten years.

Article: Would drugs be safe for us without animal tests?

Week 5 Video Lecture